表观遗传学
癌症研究
综合应力响应
肺癌
转移
老化
生物
效应器
ATF4
肺
未折叠蛋白反应
癌变
医学
限制
癌症
转录组
细胞应激反应
基因
免疫学
肿瘤发生
癌细胞
自噬
细胞生物学
谱系(遗传)
机制(生物学)
战斗或逃跑反应
基因表达
谷氨酰胺
作者
Angana A. H. Patel,Jozefina J. Dzanan,Kevin X. Ali,Ella Ä. Eklund,Samantha Alvarez,Dorota Raj,Martin Dankis,Ilayda Altinönder,Maria Schwarz,Kristell Le Gal,E. Bedel,Ahmed E. El Zowalaty,Emma Jonasson,Heba Albatrok,Nadia Gul,Jozef P. Bossowski,Ray Pillai,Patrick Micke,Johan Botling,Levent M. Akyürek
出处
期刊:Nature
[Nature Portfolio]
日期:2026-03-11
卷期号:652 (8112): 1339-1348
被引量:5
标识
DOI:10.1038/s41586-026-10216-0
摘要
. Here we show that ageing reprograms the evolutionary trajectory of KRAS-driven lung adenocarcinoma, limiting primary tumour growth while promoting metastatic dissemination through epigenetic activation of the integrated stress response (ISR). The ISR effector ATF4 drives epithelial and metabolic plasticity, conferring metastatic competence. Mechanistically, aged tumour cells show increased sensitivity to the PERK-eIF2α arm of the unfolded protein response, sustaining persistent ATF4 signalling. Targeting ISR-ATF4 genetically or pharmacologically abolishes these adaptations and limits dissemination, whereas ATF4 overexpression alone is sufficient to induce metastasis. The ageing-ATF4 axis imposes a dependency on glutamine metabolism, revealing a therapeutically actionable vulnerability. Clinical analyses confirm that ATF4 is enriched in aged tumours and correlates with poor survival and advanced-stage disease. Collectively, these results define epigenetic ISR-ATF4 activation as a causal driver of lineage plasticity and metastasis in aged tumours, revealing a therapeutic opportunity in older patients with lung adenocarcinoma, the most common yet understudied subset of lung cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI